Bleeding Risk Increased With NSAID Use for VTE Patients Receiving Anticoagulants
More than twofold increased bleeding rate seen with NSAID use for patients treated with oral anticoagulants for VTE
Tirzepatide Yields Sustained Weight Reduction in Obesity, Prediabetes
Three years of tirzepatide also reduced risk for progression to type 2 diabetes compared with placebo
ChemoRT Then Immunochemotherapy Then Surgery Promising in Unresectable Esophageal Cancer
One-year progression-free survival, overall survival was 79.4, 89.6 percent; significantly longer survival seen in patients who achieved resectability
AHA: AI Analysis of Images, Videos Can ID Early Hypertension, Diabetes
Authors say technology may enable noninvasive screening
Beta Blockers May Cause Depressive Symptoms
Findings seen in patients following myocardial infarction
Deep Learning Model Accurately Assesses Fetal Head Position
Best performance achieved with model that differentiates occiput anterior position
Oral Infigratinib Seems Safe for Children With Achondroplasia
At dose of 125 mg/kg body weight, oral infigratinib results in increased annualized height velocity and z score
AHA: Rising Outdoor Temperatures Tied to Higher Risk for Atrial Fibrillation
Doubling to tripling of odds seen when temperatures reach extreme heat levels
Risk for Mortality Up With Low Income in Type 2 Diabetes
More prominent increase in mortality risk seen for younger adults aged 20 to 39 years
More Than Four in 10 U.S. Adults Have Fatty Liver Disease
Higher risk seen among men, those 40 years and older, those with higher body mass index, and people with other comorbidities
